Odorant identity is represented in the olfactory bulb (OB) by the glomerular activity pattern, which reflects a combination of activated odorant receptors (ORs) in the olfactory epithelium. To elucidate this neuronal circuit at the molecular level, we established a functional OR identification strategy based on glomerular activity by combining in vivo Ca 2+ imaging, retrograde dye labeling, and single-cell RT-PCR. Spatial and functional mapping of OR-defined glomeruli revealed that the glomerular positional relationship varied considerably between individual animals, resulting in different OR maps in the OB. Notably, OR-defined glomeruli exhibited different ligand spectra and far higher sensitivity compared to the in vitro pharmacological properties of corresponding ORs. Moreover, we found that the olfactory mucus was an important factor in the regulation of in vivo odorant responsiveness. Our results provide a methodology to examine in vivo glomerular responses at the receptor level and further help address the long-standing issues of olfactory sensitivity and specificity under physiological conditions.
Introduction
The mammalian olfactory system has a remarkable ability to discriminate a wide variety of odorants (Buck, 2004; Firestein, 2004; Mombaerts, 2004; Touhara, 2002) . The odorant information received by olfactory sensory neurons (OSNs) in the olfactory epithelium (OE) is integrated into the primary olfactory center, the olfactory bulb (OB), and further transmitted to the olfactory cortex in which olfactory perception is constructed (Buck, 2004; Mori et al., 2006; Xu et al., 2003) . The initial step of olfaction is the binding of volatile compounds to odorant receptors (ORs), which include approximately 1000 members of the G protein-coupled receptor superfamily (Buck and Axel, 1991) . Each OSN expresses only a single OR gene (Chess et al., 1994; Serizawa et al., 2000) ; therefore, the OR plays a pivotal role in defining the odorant responsiveness of individual OSNs in the OE.
Since the OR gene superfamily has been discovered, the ligands for more than 20 ORs have been identified using various heterologous expression systems (Kajiya et al., 2001; Saito et al., 2004; Shirokova et al., 2005; Wetzel et al., 1999) or isolated OSNs expressing a particular OR of interest (Bozza et al., 2002; Malnic et al., 1999; Touhara et al., 1999) . Each OR possesses a relatively broad ligand spectrum with a low ligand affinity and recognizes a distinct but sometimes overlapping set of odorants (Araneda et al., 2000; Katada et al., 2005; Luu et al., 2004) . For example, the MOR174-9 gene encodes the mouse OR for eugenol (mOR-EG), which has been shown to recognize approximately 25 structurally related agonists and three antagonists with different potencies when expressed in HEK293 cells (Kajiya et al., 2001; Katada et al., 2005; Oka et al., 2004a Oka et al., , 2004b . These extensive studies on individual ORs have demonstrated that each OR recognizes more than one odorant and that each odorant is recognized by a unique combination of ORs, suggesting that odor quality is determined by a combinatorial receptor-coding scheme.
Odorant representation in the OB has been examined extensively using several imaging methods (Fried et al., 2002; Rubin and Katz, 1999; Uchida et al., 2000; Wachowiak and Cohen, 2001; Xu et al., 2000) and using various neuronal activity markers (Guthrie and Gall, 1995; Johnson and Leon, 2000) . Individual odorants activate distinct subsets of glomeruli in a stereotyped region of the OB, resulting in the construction of a glomerular activation pattern that is unique for each odorant. Anatomical and molecular evidence indicates that approximately 10,000 OSNs expressing the same OR send their axons to a few topographically fixed glomeruli in the OB, indicating that the pattern of activated glomeruli reflects the combination of activated ORs in the OE (Mombaerts et al., 1996; Ressler et al., 1994; Vassar et al., 1994) . Thus, odorant molecular features decoded in the OE are translated to a spatial glomerular activity pattern, which is called the ''odor map'' (Mori et al., 2006; Shepherd, 1994) .
Despite increasing information on odorant-OR interactions in peripheral OSNs and spatial odorant representations in the OB, gene-targeting and transgenic techniques have been required for exploring the projection, positional patterns, and in vivo responses of ORdefined glomeruli (Belluscio et al., 2002; Mombaerts et al., 1996; Serizawa et al., 2000; Strotmann et al., 2000; Zheng et al., 2000) . Because of the difficulty in determining the OR repertoire expressed in odorant-activated glomeruli in the OB, a comprehensive understanding of how the odor map is formed at the molecular level has not yet been obtained. Due to this technical limitation, whether the odor map in the OB truly corresponds to the receptor code in the OE has not yet been determined.
To address this issue, using mOR-EG transgenic mice, we established a technique to identify OR genes that are expressed in OSNs innervating glomeruli activated by a given odorant. We then examined the detailed functional and spatial characteristics of OR-defined glomeruli in the mouse OB as well as the relationship between the pharmacology of ORs in isolated OSNs and the responsiveness of the corresponding glomeruli. ORdefined glomeruli exhibited different ligand spectra and far higher sensitivity compared to the pharmacological properties of ORs demonstrated in vitro. Moreover, we provide evidence that the olfactory mucus is an important factor regulating the odorant responsiveness of ORs in vivo. Our results provide important insights into the mechanisms underlying the formation of odorant representation in the OB under physiological conditions at the receptor level.
Results

mOR-EG Transgenic Mice
To investigate the odorant response of a glomerulus innervated by mOR-EG-expressing neurons, we generated transgenic mice carrying a mOR-EG-IRES-gapEGFP transgene. A 9.4 kb mOR-EG genomic fragment containing 3.0 kb upstream of transcription start sites and 1.4 kb downstream of the coding region was used to construct the transgene ( Figure 1A ). The IRES sequence allows for coexpression of an OR with a reporter protein. We obtained three transgenic lines (TgA, TgB, and TgC) with a strong green fluorescent protein (GFP) signal in the OB (see Figure S1 in the Supplemental Data available online). Although the number of GFP-positive OSNs varied between the three lines, GFP-labeled neurons were always distributed within the most dorsal part of the OE (zone 1) where endogenous mOR-EG is expressed (Oka et al., 2004b) (Figure S1 ).
The main GFP-positive glomerulus (mOR-EG glomerulus) was invariably located in the antero-lateral region of the dorsal OB in all lines, while a few small additional glomeruli were observed in some lines (Figures 1B and S1) . The variations between the three lines are likely due to the copy number or locus where the transgene was inserted as previously shown for MOR23 (Vassalli et al., 2002) . Immunohistological staining of the OB coronal sections revealed that the main fluorescent glomerulus was exclusively innervated by GFP-expressing OSNs in all lines ( Figure 1C ). Transgene-derived mOR-EG was not coexpressed with the endogenous mOR-EG gene in OSNs (data not shown), indicating that the 9.4 kb genomic fragment was sufficient to ensure mutually exclusive expression of the mOR-EG transgene. ) or grayscale (intrinsic) images, wherein red or black correspond to the greatest response. Scale bar, 30 mm. The responses to different concentrations of EG were quantified and are shown as a percentage of the maximum response and fitted to the doseresponse curve (bottom, 6SE, n = 3-4).
Imaging of Odorant Responses in the mOR-EG Glomerulus Next, we examined the odorant response of the main glomerulus in mOR-EG transgenic mice. The OB was illuminated at 650 nm for intrinsic imaging or at 540 6 15 nm for Calcium Green (CG)-1-based Ca 2+ imaging under freely breathing conditions (w2.5 Hz). Stimulation with 180 nM EG (10% dilution) elicited a maximum Ca 2+ signal (DF/F = 2.5% 6 0.3%; n = 12) and intrinsic signal (DI/I = 0.09% 6 0.01%; n = 9) ( Figure 1D ). The response amplitudes in the mOR-EG glomerulus increased in a dose-dependent manner, with an EC 50 of 59 nM (1.0% dilution) for Ca 2+ imaging and 74 nM (1.5% dilution) for intrinsic imaging ( Figure 1D , bottom). Threshold vapor concentrations were between 20 and 60 nM for both Ca 2+ and intrinsic imaging. Notably, the EC 50 value of the mOR-EG glomerulus for EG was w1000-fold lower than that obtained in HEK293 cells (46 mM) or mOR-EG-expressing isolated OSNs (51 mM) (see Figure 7) . We observed no differences in odorant responsiveness between transgenic and endogenous mOR-EG glomeruli (data not shown).
Retrograde Dye Labeling for Functional OR Cloning
Each odorant activates a distinct subset of glomeruli in the OB, which is supposed to reflect a receptor code for an odorant in the OE. To elucidate the neuronal circuit at the molecular level and to determine which OR genes are expressed in activated glomeruli, we next established a functional OR-cloning methodology based on in vivo glomerular activity by combining three techniques: Ca 2+ imaging, retrograde dye labeling, and single-cell RT-PCR.
To establish this methodology, we took advantage of mOR-EG transgenic mice whose mOR-EG glomerulus can be visualized with GFP. We injected DiI into a mOR-EG glomerulus for retrograde labeling of the cell bodies of OSNs expressing mOR-EG ( Figure 2A , upper row; n = 3 mice). Dye injection was performed by using the GFP signal to identify the precise location of glomerulus. Less than 0.1 ml of 3% DiI (w/v) in dimethyl formamide was pressure-injected via a glass microcapillary tube with a diameter of w2 mm. The injection size was typically 50% to 80% of a single glomerulus, depending on the size of the target glomerulus. Under these conditions, ''contamination'' with DiI in nontargeted glomeruli or surface nerve layers was minimized. Thus, the average size of the injected area in mOR-EG transgenic mice was 84.4 6 7.3 mm (n = 3) in diameter, because the diameter of the GFP-positive mOR-EG glomerulus was 168 6 9 mm (n = 8, TgA), which was larger than the intact glomerular size due to transgene expression ( Figure 2A , upper row). Twenty-four to 36 hr after injection, 72% 6 11% (n = 3) of DiI-labeled OSNs in the OE were GFP positive ( Figure 2A , bottom row), and 51% 6 9% (n = 3) of GFP-positive cells were stained with DiI. These results indicate that the majority, but not all, of DiI-stained cells expressed mOR-EG. A higher amount of DiI or a larger diameter capillary tube increased the number of labeled OSNs that innervated nontargeted glomeruli. Next, we isolated DiI-stained cells and confirmed mOR-EG expression by single-cell RT-PCR in 6 out of 9 stained cells ( Figure 2B ). Because the mOR-EG gene was amplified from all GFP-positive OSNs (12 out of 12 cells; data not shown), the three remaining DiI-stained OSNs appear to express other OR genes. Thus, the optimized methodology could identify a target OR gene in approximately 70% of DiI-stained cells.
Functional Identification of ORs in OdorantResponsive Glomeruli
Stimulation with EG, methyl isoeugenol (MIEG), and isovaleric acid (IVA) elicited dose-dependent Ca 2+ increases in distinct subsets of glomeruli in the dorsal OB (Figure 3 ). The threshold concentrations of these odorants were between 10 29 and 10 28 M in the air phase. Increasing odorant concentrations resulted in activation of additional glomeruli. We found three glomeruli that exhibited lower EC 50 values for EG than the mOR-EG glomerulus in the dorsal OB (EC 50 = 6.5, 14, and 26 nM for glomeruli Ea, Eb, and Ec; Figure 3A ). The Ea glomerulus (glom. Ea), which was the most sensitive to EG, also responded to MIEG at concentrations as low as 1 nM (EC 50 = 3.3 nM; Figures 3A and 3B ). The Ma glomerulus (glom. Ma) showed a response to MIEG with an EC 50 value of 2.3 nM (n = 5) but not to EG ( Figure 3B ). Glomerulus Ia (glom. Ia) was one of the most IVA-sensitive glomeruli, with an EC 50 value of 97 nM, and was located in the medial-posterior region of the dorsal OB ( Figure 3C ).
To identify the ORs that are expressed in these glomeruli, we adopted the functional OR cloning method that was established using mOR-EG transgenic mice. First, we used degenerate primers to identify OR genes from DiI-positive isolated OSNs (Table S1 ). Next, specific primers were generated for the most frequently amplified OR genes (one to four genes for each glomerulus), and PCR amplification was performed on the same set of samples. An OR that was amplified from typically more than half of the population was considered as a candidate OR. For example, using degenerate primers, the MOR224-9 gene was amplified from 3 of 34 DiI-positive OSNs obtained by injection of DiI into glom. Ea (Table S1 ), and we confirmed the expression of this gene in 16 out of the 34 cells using specific primers ( Figure 4A ). In the same way, we cloned the MOR224-5 gene (19/34 cells from 7 mice) from OSNs innervating glomerulus Eb (glom. Eb), the MOR224-13 gene (9/13 cells from 3 mice) from glomerulus Ec (glom. Ec), and the MOR204-34 gene (10/14 cells from 3 mice) from glom. Ma using specific primers ( Figure 4A ). A single OR gene was always amplified from a single isolated OSN using specific or degenerate primers. MOR224-9, MOR224-5, and MOR224-13 belong to the same subfamily, with 65%-93% amino acid sequence identity. For glom. Ia, out of 17 DiI-positive OSNs, we identified the MOR31-2 gene in nine cells by using degenerate primers and confirmed the expression of MOR31-2 in ten cells with specific primers ( Figure 4A ). MOR31-2 turned out to be the S18 receptor, which has previously been shown to be a receptor for carboxylic acid (Malnic et al., 1999; Saito et al., 2004) .
We performed two independent experiments to confirm that the identified ORs really confer odorant responsiveness to the glomeruli. First, because a small amount of OR mRNAs are transported to the axon terminal of OSNs in the OB (Ressler et al., 1994; Vassar et al., 1994) , we sucked up the activated glomerulus and directly performed single glomerulus RT-PCR ( Figure 4B ). We were able to precisely locate the single target glomerulus using the CG-1 signal as a landmark. To prevent contamination from axons expressing a nontarget OR, Shown are odorant response maps evoked by EG (A), MIEG (B), and IVA (C). Higher concentrations of odorants activated larger populations of glomeruli. EG and MIEG activate overlapping sets of glomeruli in the dorsolateral region (A and B), whereas IVA activates distinct subsets of glomeruli in the dorso-medial region (C). In all panels, the vapor concentrations (nM) and dilution rate (% in mineral oil) are shown above the pseudocolored images. The pseudocolored images show the change in fluorescent intensities before and after odor stimulation is shown, wherein red corresponds to the greatest response. The graphs show the doseresponse curves for each glomerulus. The dashed boxes indicate the position of the magnified images from each response map. Odorant responses are shown as a percentage of the maximum response of each glomerulus and are fitted to the dose-response curve (6SE, n = 3).
Neuronwe first peeled off the surface nerve layer and then sucked up the target glomerulus with a sterilized capillary tube ( Figure 4B , left). As expected, each OR gene fragment was specifically amplified from the cDNA of a counterpart glomerulus ( Figure 4B , right). MOR224-5 mRNA was not detected in glom. Eb, probably due to a low level of mRNA in OSNs, as shown in Figure 4A . It is of note that the target OR gene could not be amplified after intrinsic imaging due to the lack of a positional indicator.
Second, we examined the odorant responsiveness of the identified ORs by expressing them in HEK293 cells ( Figure 4C ). Increases in intracellular Ca 2+ were observed upon ligand stimulation of each OR when coexpressed with Ga 15 and receptor-transporting proteins (RTPs) (Saito et al., 2004) . Approximately 3% of total cells were odorant-responsive for MOR224-9 and MOR224-5 (to 1 mM EG and MIEG), w5% for MOR224-13 (to 1 mM EG), w15% for MOR31-2 (to 300 mM IVA), and w60% for MOR204-34 (to 1 mM MIEG). The efficiency of odorant responsiveness appears to vary greatly between ORs in HEK293 cells. The Ca 2+ responses were also observed without RTP proteins for MOR204-34 (w20% of total cells) and MOR31-2 (w5%) (data not shown).
Odorant Response Properties of OR-Defined Glomeruli
Next, we performed Ca 2+ imaging in the OB to examine in vivo odorant specificities of glom. Ea (MOR224-9), glom. Eb (MOR224-5), glom. Ec (MOR224-13), and glom. Ma (MOR204-34) using several odorants that are structurally related to EG or MIEG. Figure 5A shows the response of each glomerulus to the odorants in the same animal. The response amplitudes evoked by stimulation with various odorants were averaged and represented as a percentage of the maximum response in each glomerulus (n = 6, Figure 5B ).
Glom. Ea responded to a broad range of EG-related odorants but not to methyl eugenol (MEG) or benzyl isoeugenol (BIEG). Glom. Eb had a similar response profile to glom. Ea, except that acetyl IEG (AIEG) did not evoke a response. Glom. Ec was activated not only by EG and vanillin but also by BIEG and AIEG, which has relatively high molecular weights. All three of these (glom. Ea, Eb, RT-PCR products from single activated glomeruli are shown (right). The inability to amplify the MOR224-5 gene is probably due to the low mRNA level in OSNs (see Figure 4A ). (C) Reconstitution of identified ORs in HEK293 cells. Representative Ca 2+ -response profiles of HEK293 cells expressing identified ORs are shown. EG (1 mM), MIEG (1 mM), VA (300 mM), IVA (300 mM), or HA (300 mM) was applied for 15 s at the time indicated by arrows at intervals of at least 2 min. VA, valeric acid; HA, heptanoic acid.
and Ec) responded only to odorants that possess a benzene ring and exhibited broad but overlapping ligand specificities. Our observations support the contention that glomeruli expressing homologous ORs within the same subfamily tend to possess similar responsiveness in vivo. In contrast to these three EG-sensitive glomeruli, glom. Ma showed a relatively narrowly tuned response spectrum, such that only MEG and MIEG evoked the highest response. In addition, very small responses were observed for acetyl EG and AIEG, but no response was observed for compounds containing larger substituent (BIEG). Our data demonstrate that MOR204-34 represented in glom. Ma has high selectivity for polarity and size at the R4 position, such that a small ether group (especially a methoxy group) at the R4 position of the benzene ring is required for ligand activity.
Spatial Distribution of OR-Defined Glomeruli in the OB For these five OR-defined glomeruli, we examined the spatial distribution in the OB. The positional relationship varied considerably between animals ( Figures 6A and  S2 ). For example, glom. Ea was located posterior to glom. Eb in 7 out of 17 animals, whereas this relative position was reversed in the other animals ( Figure S2 ). The positional reversal along the anterior-posterior axis was frequently observed for every pair combination among glom. Ea, Eb, and Ma. No correlation was found for the position of each pair of glomeruli. In contrast, along the lateral-medial axis, there was a high correlation between, for example, Ea and Ma (Ea was lateral to Ma in 14/15 animals; r = 0.82) and between Ea and Eb (Ea was lateral to Eb in 15/17 animals; r = 0.6). In addition, the position of the glomeruli sometimes differed considerably between the left and right OB (Figure 6A, lower) . No positional correlation was found between the left and right glomeruli along the anterior-posterior or the lateral-medial axis (n = 6 mice), suggesting that the positional relationship among glomeruli was not maintained between the left and right OBs. Figure 6B shows the location of each glomerulus based on the distances from the caudal sinus (x) and the intersection of the midline (y) in millimeters. The average position of each glomerulus (x, y) was as follows: (1.4 6 0.17, 1.6 6 0.14) for Ea, (1.4 6 0.17, 1.5 6 0.11) for Eb, (2.1 6 0.18, 1.6 6 0.11) for Ec, (1.5 6 0.16, 1.5 6 0.14) for Ma, and (1.9 6 0.15, 0.98 6 0.08) for Ia. Each glomerular domain occupied 5.2%, 3.8%, 6.8%, 3.3%, and 2.2% (for glomeruli Ea, Eb, Ec, Ma, and Ia, respectively) of the total imaged area (dotted line in Figure 6B ). These sizes were approximately the same or slightly larger than the functional domain as previously defined by glomerular activity patterns in the OB (Belluscio and Katz, 2001; Uchida et al., 2000) . Unlike the stereotyped ''odor map,'' our results show a precise bulbar ''ORmap'' that appears to differ between individual animals.
Pharmacological Properties of ORs In Vivo versus In Vitro
The response properties of glomeruli are thought to reflect OR pharmacology observed in a heterologous expression system or in isolated OSNs. To explore this idea in more detail, we directly compared the in vivo ligand specificities of OR-defined glomeruli with the pharmacological properties of ORs in vitro. We used mOR-EG tagged with an additional sequence of 20 N-terminal amino acids of bovine rhodopsin in this study, as no difference was observed between tagged and intact mOR-EG in the HEK293 cell line. For mOR-EG, vanillin was a potent agonist at the receptor level in vitro ( Figures  7A, left, and 7B) . Specifically, the EC 50 values were 51 mM for EG and 33 mM for vanillin in isolated OSNs (n = 3 cells) and 46 mM for EG and 26 mM for vanillin in HEK293 cells (n = 4) ( Figure 7B) . In HEK293 cells, we observed a difference in IEG-responsiveness as measured by Ga 15 -mediated Ca 2+ imaging and Gas-mediated cAMP elevation ( Figure 7B ), probably due to the difference in receptor coupling to Ga 15 and Gas (Shirokova et al., 2005) .
In the mOR-EG glomerulus, however, we observed a modest response or no response to vanillin and 4-hydroxy-3-methyl benzaldehyde (4H3MBA), which are potent agonists of mOR-EG-expressing OSNs and HEK293 cells ( Figure 7A , right, and 7B). The threshold concentration for activation by vanillin in the mOR-EGglomerulus was w10-fold higher than that of EG, and the maximum response evoked by neat crystal (0.29 mM vapor concentration) was 18.5% 6 4.9% (n = 3) of that elicited by 0.16 mM EG (7.7% dilution) ( Figure 7B ). It was of particular interest that the odorant responsiveness of OSNs in vitro was different from that obtained in vivo by Ca 2+ imaging of axon terminals of OSNs in the OB.
MOR204-34 (glom. Ma) also exhibited different response profiles in vivo and in vitro. MOR204-34 was robustly activated by acetyl isoeugenol (AIEG) (300 mM) in HEK293 cells (82.8% 6 9.8% of the response elicited by 300 mM MIEG; n = 9), whereas only a small response was observed in vivo by stimulation with AIEG in glom. Ma (5.0% 6 3.7% of the response elicited by 45 nM MIEG) (Figures 7C). The EC 50 value for AIEG (55 mM) was w2.5-fold higher than that of MIEG (21 mM) in HEK293 cells, whereas the threshold concentration of AIEG was w100-fold greater than that of MIEG as determined by Ca 2+ imaging in the OB ( Figure 7C ). No difference in odorant responsiveness was observed in the results obtained by Ca 2+ imaging and those obtained by cAMP elevation assay ( Figure 7C) . Similar results were obtained for MOR224-5 (glom. Eb) and MOR224-13 (glom. Ec). The ligand spectra were slightly broader in HEK293 cells compared with those in vivo for both ORs ( Figure 7D ). MOR224-13 was observed to respond to MEG, and MOR224-5 responded to MEG and 4H3MBA in HEK293 cells, whereas these According to the pseudocolored response maps (top), the bilateral location of each OR-defined glomerulus is mapped onto the OB (bottom). Some of the activated glomeruli in the anterior region are out of focus in the pseudocolored image (for comparison, see Figure 3 ). Glom. Ea, Eb, Ec, and Ma are mapped by red, green, blue, and brown dots, respectively. The coordinates of each glomerulus were calculated as the distance from the caudal sinus and the intersection of the midline. See also Figure S2. (B) Summary of the location of each glomerulus in the OB from 10 to 17 preparations. Each glomerulus is represented by the same color as in Figure 6A . Scale bar, 500 mm.
compounds failed to evoke responses in corresponding glomeruli. We could not determine the specificity of MOR224-9 because the response efficiency was not high enough to allow careful specificity experiments in HEK293 cells. These results clearly demonstrate that in vivo odorant responsiveness at the level of the OB, wherein odorants are delivered through the air, does not necessarily exactly reflect the pharmacological properties of the OR in a heterologous expression system or in isolated OSNs, wherein odorants are delivered through an aqueous solution without mucus.
Role of Olfactory Mucus in Odorant
Response Specificity Finally, we examined the role of the olfactory mucus in odorant responses in vivo. Using the artificial sniffing system (Wachowiak and Cohen, 2001) , we recorded odorant responses in the OB, washed the nasal cavity with w5 ml Ringer's solution to remove mucosal fluid ( Figure 8B) , and recorded odorant responses again. We found that the responses of vanillin were augmented after washing out the mucus, whereas those of EG were unaffected ( Figure 8A ). In the mOR-EG glomerulus, the response amplitude (DF/F) of vanillin (neat) increased from 0.37% 6 0.06% to 1.26% 6 0.23% (n = 3), while that of EG (1%) was not significantly changed (from 1.39% 6 0.04% to 1.32% 6 0.02%, n = 3) ( Figure 8C ). These results indicate that the mucus greatly influences apparent odorant-responsiveness. The relative response specificity was calculated by dividing the amplitude of the vanillin response by that of the EG response; the results were significantly different before Figure 8C ). Although it is difficult to remove the mucus completely from the nasal cavity, these results partly explain the difference between in vitro and in vivo OR responses.
Discussion
In this study, we used mOR-EG transgenic mice to establish a technique for functional OR identification based on glomerular activity. Using this technique, we directly linked in vivo glomerular activity in the OB with the corresponding ORs. Extensive functional analysis of OR-defined glomeruli revealed that the OR pharmacology in vitro is not exactly reflected by the in vivo responsiveness of the glomerulus in the OB. Thus, ORdefined glomeruli tended to exhibit higher sensitivity and specificity compared to the pharmacological properties of the ORs in vitro. To our knowledge, we described for the first time in vivo odorant responses at receptor level and provided insights into our understanding of how the in vivo OR code is formed under physiological conditions.
Linking ORs with Odorant Response Properties in Glomeruli
We developed a methodology for identifying the ORs expressed in OSNs innervating activated glomeruli using Ca 2+ imaging followed by retrograde dye labeling and single-cell RT-PCR. Although this approach has long been proposed (Bozza and Kauer, 1998; Mizrahi et al., 2004) , to date, the ORs associated with specific odorant-activated glomeruli have not been reliably identified. For several ORs, gene-targeted or transgenic mice coexpressing fluorescent marker protein and an OR of interest have been generated to visualize single glomeruli in the OB. In a single case, using gene-targeted mice in which the rat I7 receptor was ectopically replaced with the intact M71 receptor gene, ligand odorants were shown to activate rat I7 glomeruli in the mouse OB (Belluscio et al., 2002) . A detailed pharmacological analysis of intact OR-defined glomeruli, however, has not yet been performed.
In this study, we successfully linked five ORs with their odorant responses in corresponding glomeruli. Importantly, we were able to identify ORs from all target glomeruli tested in this study (5/5 glomeruli), demonstrating the high efficiency and reliability of our methodology. The expression of the identified OR in the defined glomerulus was confirmed by single-glomerulus RT-PCR. Moreover, the identified ORs expressed in HEK293 cells recognized the odorants that were shown to elicit responses in the OB. Expansion of imaging areas in the OB would allow us to determine a complete set of ORs for a given odorant, which corresponds to an in vivo receptor code representing the odor quality of the odorant.
Odorant Sensitivity of OR In Vitro versus Glomerulus In Vivo
It has long been known that odorant concentrations required for activation of ORs in isolated OSNs or in heterologous expression systems are unreasonably high; micromolar and sometimes millimolar concentrations are used in aqueous solutions (Mombaerts, 2004) . Indeed, the threshold concentrations of ligands for ORs are reported to be 10 26 to 10 25 M in OSNs or in HEK293 cells, suggesting that ORs are a relatively low-affinity class of G protein-coupled receptor (Bozza et al., 2002; Kajiya et al., 2001) . In contrast to in vitro experiments, much lower concentrations of odorants can elicit responses in glomeruli in vivo, as assessed by imaging or behavioral responses (Lin et al., 2004; Mombaerts, 2004; Rubin and Katz, 1999) . To address this discrepancy, we directly compared the in vitro odorant responsiveness of ORs in OSNs and in HEK293 cells with the in vivo responsiveness in the corresponding glomeruli. OR-defined glomeruli exhibited far higher sensitivity to ligands (w10 28 M in air phase) than in isolated OSNs or HEK293 cells (see Figures 3 and 7) . Our Ca 2+ imaging data demonstrated that the odorant sensitivity of an OSN isolated from the OE was different from the sensitivity of its axon terminal in the OB, raising the possibility that the olfactory mucus, airflow rate, or unique structure of the mammalian nasal cavity influences odorant responsiveness by helping to concentrate odorants (up to 1000-fold for EG) at a local receptor site from the airflow. Consistently with this, an increase in airflow in the nasal cavity during artificially controlled sniffing resulted in greatly increased sensitivity in ORdefined glomeruli, indicating that airflow rate is an important factor determining olfactory sensitivity in vivo (unpublished data).
Odorant Specificity of OR In Vitro versus Glomerulus In Vivo
Interestingly, the odorant specificity was also different in the glomerulus and isolated OSNs. For example, vanillin and 4-hydroxy-3-methyl-benzaldehyde evoked slight responses in the mOR-EG glomerulus, whereas the same concentrations of these odorants induced robust responses in mOR-EG-expressing OSNs or HEK293 cells. Furthermore, vanillin was a slightly more potent agonist than EG in isolated OSNs or in HEK293 cells, whereas the relative potency was reversed in the OB in vivo (Figure 6 ). Similar results were observed for MOR204-34 ( Figure 6D ) as well as for MOR224-5 and MOR224-13, clearly demonstrating that the in vivo response in the OB does not faithfully reflect the in vitro pharmacological properties of the OR.
Recent studies revealed a mechanism for inhibition of presynaptic input via a neuronal circuit in the OB . Although this could explain our observations, it is not likely in this case because presynaptic inputs appear to be modulated only by intraglomerular inhibition and not by lateral inhibitory connections between glomeruli . Indeed, we found that blocking of excitatory input from OSNs by application of CNQX/APV had no significant effect on the responses to vanillin or 4-hydroxy-3-methylbenzaldehyde in the axon terminal of OSNs (data not shown), excluding the possibility of such an interneuronal inhibition.
The alternative explanation for the difference between the in vitro and in vivo responsiveness is the solubility of odorants in olfactory mucus. Solubility in mucosal fluid is known to vary considerably between odorants depending on their chemical properties (Kurtz et al., 2004) , which may result in different odorant concentrations in the mucus. Interactions with mucosal proteins such as odorant-binding proteins or metabolic enzymes may also greatly affect the local concentration of an odorant at the receptor site in vivo. Indeed, washing out the mucus from the nasal cavity resulted in an augmentation of the response to vanillin in the mOR-EG glomerulus, leading to changes in odorant specificity, which partly explains the in vivo and in vitro discrepancy in response specificity. Differences in local concentrations of odorants may, therefore, lead to apparent changes in odorant responsiveness in the OB. Since the in vivo codes for odorants in the OB appear to be different than the in vitro OR codes, we should be careful about relying on combinatorial receptor-coding schemes based on in vitro odorant-OR matrices obtained in mammalian cell lines or isolated OSNs.
OR Map in the OB
In this study, we found that the position of five ORdefined glomeruli greatly varied between animals regardless of the similarity of the OR sequence or its ligand specificity. Similarly, the relative position of glomeruli innervated by OSNs expressing the mOR37 gene family exhibits different local permutations (Strotmann et al., 2000) . Our positional correlation analysis revealed that reversal of the relative position frequently occurred on the anterior-posterior axis but rarely on the lateralmedial axis. If glomerular positioning were totally random, the frequency of positional reversal should be the same for both axes. In light of this, our results indicate that different factors may be involved in positioning relative to the anterior-posterior and lateral-medial axes (Miyamichi et al., 2005) . We also found positional differences between left and right glomeruli in the same animal, consistent with previously observed differences in odorant activation patterns between the left and right OBs (Belluscio and Katz, 2001 ). These results imply that genetic background and odor experience have no apparent effect on glomerular positioning. Further study would be necessary to elucidate the effect of these positional differences on individual odor perception, or the factors determining relative glomerular position in the OB. In this study, by examining the pattern of glomerular activity at the individual OR level, we demonstrated that the OR map is not fixed in the OB, and therefore, the odor map in the OB can be truly described only when repeatedly examined using multiple animals.
In summary, we successfully linked the glomerular activity pattern to the corresponding ORs, and we mapped these OR-defined glomeruli in the OB. By directly comparing the in vitro and in vivo OR responses, we demonstrated that odorant specificity tends to be more narrowly represented, with much higher sensitivity, in glomeruli in vivo than in ORs in vitro. Our results also imply an important role for the olfactory mucus in regulating odorant responsiveness under physiological conditions. The current study describes a methodology that enables exploration of the odor map in the OB at receptor level and, therefore, provides previously unappreciated implications for the in vivo odorant-recognition mechanism.
Experimental Procedures mOR-EG Transgenic Mice
Genomic clones containing mOR-EG were isolated from a Lambda FIX phage library from a 129/SvJ mouse. The 8.0 kb KpnI/PvuII fragment comprising the sequences between the KpnI site at 5.6 kb upstream of the mOR-EG start codon, and the PvuII site in the 3 0 untranslated region (2.4 kb) was subcloned into pBluescript SK II vector (Stratagene). A SacII-NotI site was engineered downstream of the stop codon to produce plasmid mOR-EG/SacII/NotI. The SacII/NotI insert of IRES-gapEGFP, which encodes an internal ribosome entry site (IRES) and a fusion protein consisting of the N-terminal 20 amino acids of GAP-43 and EGFP, was ligated to generate the transgene mOR-EG-IRES-gapEGFP. Gel-purified transgenes were microinjected into the pronucleus of fertilized eggs that were obtained from mating C57BL/6 and DBA/2J mice. Founders were bred with C57BL/6 mice. All animal experiments were approved by the Animal Care Committee of the University of Tokyo.
In three lines, we found different GFP expression patterns in the OB ( Figure S1 ). Despite the line variation, the main GFP-positive glomerulus was observed in the dorsal OB in all lines, and we observed no differences in odorant responsiveness of the main glomerulus between the lines. The data from each line were thus pooled for quantitative analysis. Ca 2+ imaging and intrinsic imaging in the OB were performed on 4-to 8-week-old C57BL/6 mice or mOR-EG transgenic mice as described previously (Fried et al., 2002; Rubin and Katz, 1999; Uchida et al., 2000; Wachowiak and Cohen, 2003) . For Ca 2+ imaging, OSNs were loaded with CG-1 dextran (Molecular Probes, Eugene, OR). Under anesthesia with ketamine (90 mg/kg) and xylazine (10 mg/kg), 1.5 ml of dye solution (6% in Ca 2+ -free Ringer's solution) was perfused into the nasal cavity using a shortened gel-loading tip. Perfusion was repeated at 3 min intervals until a total volume of 6-8 ml was injected. This volume was sufficient to load the OSNs innervating the overall dorsal part of the OB with enough fluorescent dye to provide a strong signal. Bilateral imaging was performed in six mice by perfusing both sides of the nasal cavity with dye solution. Ca 2+ imaging was performed 3-7 days after dye loading.
Recording of Odorant Responses in the OB
Mice were anesthetized by subcutaneous injection of ketamine (70 mg/kg) and medetomidine (0.5 mg/kg). Using a dental drill, the skull overlying the dorsal surface of the OB was thinned and removed while leaving the dura intact. The exposed area was then filled with 1.5% agarose gel and covered with a cover glass. Because a significant difference was not observed in odorant-evoked spatial patterns between artificially sniffing (3.3 Hz) and freely breathing (w2.5 Hz) animals, all experiments were performed under the freely breathing condition. The breathing rate was between 2.0 and 2.5 Hz during the experiments. For fluorescent Ca 2+ imaging in the OB of C57BL/6 mice, the excitation wavelength was 500 6 25 nm, and emitted light at wavelengths above 530 nm was collected using a 525 nm dichroic mirror. For mOR-EG transgenic mice, the CG-1 signal was separated from the GFP signal using a custommade filter and a 560 nm dichroic mirror with excitation at 537 6 15 nm and emission at 565 nm. This filter had no effect on the relative signal amplitude (DF/F). For intrinsic imaging, the OB was illuminated at 650 nm and the reflected light was collected. Images were acquired using AQUA COSMOS software and an ORCA2-ER CCD camera (Hamamatsu Photonics, Hamamatsu, Japan) with a resolution of 672 3 522 pixels at 12 Hz (for Ca 2+ imaging) or 1344 3 1044 pixels at 9 Hz (for intrinsic imaging). The imaging area was 2.3 3 1.4 mm using a 103 objective lens and 5.6 3 3.4 mm using a 43 objective lens.
Odorants
Odorants utilized in this study were kindly provided by T. Hasegawa Co. Ltd. (Tokyo, Japan) or purchased from Sigma (Tokyo, Japan). The purity of some odorants was checked by thin layer chromatography or GC-MS. Odorants were prepared in a 5 ml glass tube either as a pure substance or diluted in DMSO (vanillin and IEG) or mineral oil (other odorants). Because the theoretical vapor concentration sometimes differs greatly from the actual concentration, we directly measured the vapor concentration of each odorant (both pure substance and diluted form) by GC-MS (Shimadzu, Tokyo, Japan) as described in Figure S3 .
Data Analysis
For Ca 2+ imaging, data from each trial were analyzed individually. For intrinsic imaging, we averaged three consecutive odorantevoked responses to improve the signal-to-noise ratio. The relative signal amplitude was calculated as described previously (Wachowiak and Cohen, 2001) . Briefly, the fluorescence or the reflectance of each pixel at the peak of the response was subtracted from the resting signal intensity just before the stimulus and then divided by the resting intensity to adjust for unequal dye labeling or uneven illumination. In analyses of dose-dependence, the DF/F value was quantified and is represented as a percentage of the maximum response in each glomerulus, typically evoked by one of the following: 10% EG in the mOR-EG glomerulus and glom. Ea, Eb, and Ec; 10% MIEG in glom. Ma; or 0.1% IVA in glom. Iva.
Spatial maps were constructed from each pixel's signal by subtracting the temporal average of a time window just preceding the stimulus (t1) from a temporal average centered near the peak of the response (t2), and then divided by temporal average of t1. To construct odor maps, we averaged 2.7-4.6 s for t1 and 5.5-7.8 s (Ca 2+ imaging) or 6.8-9.5 s (intrinsic imaging) for t2. After constructing the map, a Gaussian spatial filter was used for intrinsic imaging to eliminate the nonspecific responses (SD = 68 mm). For generation of figures, all maps were smoothed using a 3 3 3 pixel kernel and normalized to the maximum signal amplitude (max DF/F) for the trial. All spatial data were analyzed and processed using AQUA COSMOS software (Hamamatsu photonics) and Photoshop (Adobe).
The positional correlation between glomeruli was measured by comparing each position of the glomerulus. The glomerulus position was determined as a coordinate represented by the distance (mm) from the caudal sinus (x) and the intersection of the midline (y) as previously described (Belluscio and Katz, 2001) . After mapping each glomerulus in the OB, we analyzed the correlation between each pair of glomeruli across animals or between left and right OB for the anterior-posterior and lateral-medial axes. Correlation analysis was performed using Prism software (Graphpad Software).
Ca
2+ Imaging of HEK293 Cells Ca 2+ imaging in HEK293 cells was performed essentially as described previously (Katada et al., 2003) . Briefly, 60%-70% confluent HEK293 cells were transfected with 2.5 mg of pME18S-tagged-ORs, 1.5 mg of pME18S-Ga 15 , and 0.5 mg of RTPs using Lipofectamine 2000 (Invitrogen; 2.5 ml/mg DNA). All ORs contained additional N-terminal 20 amino acids of bovine rhodopsin. After 24-28 hr, the transfected cells were loaded with 2.5 mM Fura-2/AM for 30 min at 37 C. Odorant solutions were sequentially applied to the cells using a peristaltic pump at a flow rate of 1.5 ml/min for 15 s with a w2 min wash with Ringer's solution between stimuli.
2+ Imaging of Mouse Olfactory Neurons Olfactory neurons for Ca 2+ imaging were isolated from the OE of 4-to 8-week-old mOR-EG transgenic mice on Cell-TAK-coated glass-bottomed dishes, and Fura-2-based Ca 2+ responses were recorded as described previously (Oka et al., 2004b) . The odorant responses were recorded from GFP-positive cells. Odorant solutions were sequentially applied for 10 s with a 2.5 min wash between stimuli.
Measurement of the cAMP Level in HEK293 Cells
The level of cAMP in HEK293 cells was measured essentially as described previously (Katada et al., 2003) . Briefly, 60%-70% confluent HEK293 cells were transfected with 2.5 mg of pME18S-tagged-ORs and 0.5 mg of RTPs using Lipofectamine 2000 (Invitrogen; 2.5 ml/mg DNA). After 24 to 28 hr, cells were stimulated with odorants for 5 min, and the intracellular cAMP level was monitored using a cAMP-Screen kit (Tropix).
DiI Injection into a Glomerulus and Isolation of Innervating OSNs
After Ca 2+ imaging in the OB, the center of the odorant-activated glomerulus was pressure-injected with 3% DiI in dimethyl formamide using a glass capillary (w2 mm in diameter). The injection volume was less than 0.1 ml, which corresponded to 50%-80% of the total volume of each glomerulus. Upon injection, the OB was continuously illuminated at 500 nm to visualize both the CG-1 signal and the DiI signal. Injection of a larger volume resulted in staining of nontargeted glomeruli.
After 24-36 hr, mice were anesthetized by overdose with Mioblock (Sankyo, Japan), and the most dorsal region of the OE (zone 1) was dissociated in Ringer's solution. Longer recovery times (48 hr) after DiI injection caused changes in the properties of the cell membrane, making it difficult to collect the target cell. The OSN layer was then peeled off the epithelium with scalpel and forceps and cut into pieces. After gently triturating the pieces 8 to 12 times, dissociated cells were transferred to a glass-bottomed 35 mm dish coated with Cell-Tak (Collaborative Research, Bedford, MA) and allowed to settle and attach for approximately 15 min. To remove contaminating mRNA released during trituration, isolated OSNs were washed with Ringer's solution for at least 20 min using a peristaltic pump. DiI-stained OSNs were individually collected with a glass capillary (w10 mm in diameter) for subsequent single-cell RT-PCR.
Isolation of Single Glomeruli
To isolate mRNA from single glomeruli, the odorant-activated glomerulus was precisely located after in vivo Ca 2+ imaging using the CG-1 signal as a landmark. Mice were then sacrificed by an overdose with Mioblock, and the dura covering the dorsal surface of the OB was carefully removed with forceps. We typically used two capillaries (w30 mm in diameter) to collect each glomerulus. First, the nerve layer covering the target glomerulus was removed under a fluorescent microscope using a glass capillary, and then the OB was washed with Ringer's solution. Second, the exposed target glomerulus was directly collected with another capillary (w0.1 ml in volume). To avoid contamination from axons innervating neighboring glomeruli, we picked a portion rather than the whole glomerulus. Collected axons were used for subsequent single-glomerulus RT-PCR. Although this method ensured that identified glomeruli expressed OR genes, we were rarely able to amplify OR genes with degenerate primers because of the small amount of mRNA in the axon terminal.
Artificial Sniffing and Removal of Mucus from Nasal Cavity A double tracheotomy was conducted essentially as previously described (Wachowiak and Cohen, 2001 ). An artificial sniffing system was used to control odorant access and wash out the mucus from nasal cavity. The naris on the side at which CG-1 was injected was left open. For Ca 2+ imaging, the upper tracheotomy tube was vacuumed with negative pulse pressure (50 ml/min flow rate, 150 ms duration, 3.3 Hz) for odorant presentation. After recording, the nasal cavity was washed with w5 ml Ringer's solution using negative pressure (w30 ml/min) through the upper tracheotomy tube. Within 15 min after washing out the mucus, odorant responses were recorded again and compared with those obtained before washing. Although the effect of the mucus removal is known to continue at least 30 min and recover within a few hours (Weiler et al., 2006) , it was difficult to precisely assess the removal efficiency because the mucosal fluid is continuously secreted from glands in the nasal cavity.
RT-PCR
Isolated DiI-positive OSNs or odorant-activated single glomeruli were analyzed by RT-PCR essentially as described previously (Oka et al., 2004b) but with slight modifications. After OSNs or glomeruli were isolated in a glass microcapillary, the crude RNA was isolated from them using a Micro-to-Midi Total RNA Purification System (Invitrogen). The cDNA generated from each sample was PCRamplified using gene-specific primers or the following degenerate primers: D1, ACGGATCCATGGCCTACGACCGGTACGTNGCNAT HTG; D2, ACCTCGAGTGGGAGGCGCAGGTGSWRAANGCYTT; D3, ATGKSITWIGAYMGITWYGYIGC; D4, TWIGAYMGITWYGYIGCIRT ITG; or D5, TAIAYIAIIGGRTTIAGCAWIGG; NotI, NotI-adaptor primer pair based on d(T) 18 -NotI used for the first-strand cDNA synthesis. A first amplification was performed using D1, D3, or a specific primer and NotI. The second amplification was performed using D1 and D2, D4 and D5, or specific primer pairs. The first and second amplifications were carried out using 2.5 units/50 ml ExTaq (Takara) and with the following reaction conditions: for D1 and D2 primers, 95 C for 30 s, followed by 40 cycles of 95 C for 30 s, 40 C for 30 s, and 72 C for 1 min; or for D3, D4, and D5 primers, 95 C for 30 s, followed by 40 cycles of 95 C for 30 s, 45 C for 90 s, and 72 C for 1 min.
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